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Summary 
Ciliary neurotrophic factor (CNTF) supports motor 
neuron survival in vitro and in mouse models of motor 
neuron degeneration and was considered a candidate 
for the muscle-derived neurotrophic activity that regu- 
lates motor neuron survival during development. How- 
ever, CNTF expression is very low in the embryo, and 
CNTF gene mutations in mice or human do not result 
in notable abnormalities of the developing nervous 
system. We have generated and directly compared 
mice containing null mutations in the genes encoding 
CNTF or its receptor (CNTFRa). Unlike mice lacking 
CNTF, mice lacking CNTFRadie perinatallyand display 
severe motor neuron deficits. Thus, CNTFRa is critical 
for the developing nervous system, most likely by 
serving as a receptor for a second, developmentally 
important, CNTF-like ligand. 
Introduction 
Ciliary neurotrophic factor (CNTF) was originally identi- 
fied, and named, on the basis of its ability to promote the 
survival of parasympathetic motor neurons found in the 
embryonic chick ciliary ganglion (Adler et al., 1979; Lin et 
al., 1989; Stockli et al., 1989). CNTF also acts on a variety 
of other embryonic neurons, including peripheral sensory 
neurons (Barbin et al., 1984) sympathetic neurons (Barbin 
et al., 1984; Ernsberger et al., 1989; Saadat et al., 1989), 
hippocampal neurons (Ip et al., 1991), preganglionic sym- 
pathetic neurons (Blottner et al., 1989), and cranial and 
spinal motor neurons (Arakawa et al., 1990; Sendtner et 
al., 1990; Wewetzer et at., 1990; Oppenheim et al., 1991; 
Martinou et al., 1992; Vejsada et al., 1995). Of all the ac- 
tions of CNTF, those on motor neurons have attracted the 
most attention. In addition to its survival and differentiative 
effects on cultured embryonic motor neurons in vitro (Ara- 
kawa et al., 1990; Martinou et al., 1992), exogenously pro- 
vided CNTF can rescue motor neurons from ontogenetic 
cell death in the embryo (Wewetzer et al., 1990; Oppen- 
heim et al., 1991) and can support motor neurons following 
axotomy in newborns (Sendtner et al., 1990; Vejsada et 
al., 1995). Exogenously provided CNTF can also blunt pro- 
gression in several mouse models of motor neuron dis- 
ease (Sendtner et al., 1992a; Mitsumoto et al., 1994; Sagot 
et al., 1995), raising the possibility that CNTF may be of 
therapeutic value for motor neuron diseases in humans. 
The ability of CNTF to maintain motor neurons led to con- 
sideration of CNTFas acandidate for the long sought-after 
nerve- or muscle-derived neurotrophic activity that seem- 
ingly regulates motor neuron survival in the embryo (Ham- 
burger, 1975; Oppenheim, 1989; Wewetzer et al., 1990; 
Oppenheim et al., 1991). This neurotrophic activity is 
thought to be present in limiting amounts during the devel- 
opmental period when motor neurons contact their target 
and compete for neurotrophic support and thus apparently 
ensures survival of only those motor neurons making ap- 
propriate connections. 
Despite the impressive effects of ectopically adminis- 
tered CNTF on embryonic and adult motor neurons, as 
well as on other neuronal populations, recent analyses of 
mice and humans containing mutated CNTF genes sug- 
gest that endogenous CNTF does not, in fact, play a critical 
role in the development of motor neurons or other neuronal 
populations. Mice homozygous for null mutations in the 
CNTFgene appear remarkably normal (Masu et al., 1993). 
They are viable and initially thrive, and only later in adult- 
hood do they exhibit a very mild loss of motor neurons 
with resulting minor muscle weakness. Even more aston- 
ishingly, a study of the Japanese population has revealed 
that a significant fraction, approximately 2.5%, are homo- 
zygous for mutations that inactivate the CNTFgene (Taka- 
hashi et al., 1994). These individuals lacking CNTF are 
seemingly not adversely affected in any way and have 
not yet been shown to have any associated neurologic 
abnormalities. Consistent with this genetic evidence that 
CNTF does not play a major role during development, it 
has been shown that CNTF is normally expressed only at 
very low levels in the embryo (Stockli et al., 1991; Ip et 
al., 1993). Furthermore, CNTF lacks a signal peptide and 
is found stored inside of adult glial cells, perhaps awaiting 
release by some mechanism induced by injury (Sendtner 
et al., 1992b; Rende et al., 1992; Friedman et al., 1992). 
These studies of CNTF expression, together with the find- 
ings that mice and humans lacking CNTF develop and 
mature quite normally, have led to the suggestion that 
CNTF is not essential during development or for life but 
instead acts in response to injury or other stresses. 
CNTF is a member of a family of distantly related cyto- 
kines that includes leukemia inhibitory factor (LIF), interleu- 
kin-6(IL-6), interleukin-1 1 (IL-l l), oncostatin M (OSM), and 
cardiotrophin-1 (Bazan, 1991; Rose and Bruce, 1991; Pen- 
nica et al., 1995). CNTF utilizes a three-component recep- 
tor system consisting of a CNTF-specific binding compo- 
nent, known as CNTFRa (Davis et al., 1991), as well as two 
signal-transducing 8 receptor subunits, gpl36 and LlFRj3 
(Taga et al., 1989; Hibi et al., 1990; Gearing et al., 1991) 
which it shares with its cytokine relatives (Ip et al., 1992; 
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Gearing et al., 1992; Davis et al., 1993; Stahl et al., 1993; 
Stahl and Yancopoulos, 1993; Baumann et al., 1993; Stahl 
and Yancopoulos, 1994). These three components are all 
initially unassociated on the cell surface, but form a com- 
plex in response to CNTF. The first step in complex forma- 
tion involves the binding of CNTF to its a receptor compo- 
nent, followed by recruitment of the 6 components to form 
the complete complex; the 6 components do not bind to 
CNTF in the absence of CNTFRa (Ip et al., 1992; Davis et 
al., 1993). Complex formation, in particular, 6 component 
dimerization, initiates the signaling process by activating 
cytoplasmic tyrosine kinases (members of the Jak/Tyk 
family) that are constitutively preassociated with the cyto- 
plasmic domains of each of the 6 components (Stahl and 
Yancopoulos, 1993; Stahl et al., 1994; Lutticken et al., 
1994; Stahl et al., 1995). In contrast with the 6 compo- 
nents, CNTFRa lacks a cytoplasmic domain (it is linked 
to the surface via a glycosylphosphatidylinositol linkage) 
and plays no role in signaling (Davis et al., 1991; Stahl 
and Yancopoulos, 1994). The sole function of CNTFRa 
seems to involve specificity determination; i.e., since 
CNTF cannot bind to or activate its 6 components in the 
absence of CNTFRa, the expression of CNTFRa deter- 
mines which cells can respond to CNTF (Ip et al., 1993; 
Stahl and Yancopoulos, 1994). Thus, because the 
CNTFRa subunit is generally restricted to the nervous sys- 
tem in its expression, the actions of CNTF are largely lim- 
ited to neurons and glia (Ip et al., 1993; Stahl and Yanco- 
poulos, 1994). It is this specific expression of CNTFRa 
that underlies the role of CNTF as a neurotrophic factor, 
and which distinguishes CNTF from its more generally 
acting cytokine relatives. Other members of the CNTF cy- 
tokine subfamily, such as IL-6 and IL-1 1, also have their 
own specificity-determining a components, which are 
widely expressed outside of the nervous system, for exam- 
ple in hematopoietic cells, explaining the more general 
actions of these cytokines (Kishimoto et al., 1992; Hilton 
et al., 1994). 
CNTFRa is expressed on all cells that are known to 
respond to exogenously provided CNTF and is also ex- 
pressed on many additional embryonic and adult neuronal 
populations that have not yet been evaluated for their 
CNTF responsiveness (Ip et al., 1993). The widespread 
expression of CNTFRa in the developing nervous system 
of the embryo is consistent with the observations that ex- 
ogenously provided CNTF can act on many embryonic 
neurons, but seems perplexing if CNTFRa merely acts as 
a receptor for a factor that only acts later in life (Ip et al., 
1993). This apparent paradox has led to speculation that 
a ligand other than CNTF may also use CNTFRa and that 
this ligand might play a much more critical role during 
early development, and perhaps even in the adult, than 
does CNTF (Ip et al., 1993). To explore this possibility, 
we have generated and compared mice containing null 
mutations in either the gene encoding CNTF or that encod- 
ing CNTFRa. In contrast with mice lacking CNTF, mice 
lacking CNTFRa die shortly after birth and exhibit pro- 
found deficits in all motor neuron populations examined. 
These mice provide compelling genetic evidence that 
CNTFRa does indeed play a critical role in the developing 
nervous system, most likely by serving as the receptor for 
a second, developmentally important, CNTF-like factor. 
Results 
Contrasting Phenotypes Result from CNTF 
and CNTFRa Genetic Mutations 
Replacement vectors were constructed and employed in 
positive-negative selection protocols, involving succes- 
sive G418 and gancyclovir selections (Mansour et al., 
1988) intended to disrupt either the CNTF or CNTFRa 
genes by homologous recombination in embryonic stem 
(ES) cells (Figures 1 and 2). Successful targeting of the 
CNTF gene was achieved in 4 of 82 transfected clones 
surviving the double selection, while succesful targeting 
of the CNTFRa gene was achieved in 2 of 180 ES clones 
screened. Male chimeras derived from each of these 
clones were bred with C57BU6 females. All four of the 
CNTF gene-targeted clones transmitted the mutant allele 
to the Fl generation, while one of the CNTFRa gene-tar- 
geted clones transmitted the mutant allele through the 
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Figure 1. Targeting of the Murine CNTF Gene 
(A) Schematic representation of the 12.5 kb BamHl genomic DNA 
fragment encompassing the endogenous CNJFgene, of the targeting 
vector constructed, and of a mutant locus following successful tar- 
geting. The two exons of the CNJF gene are indicated as boxes, with 
coding portions in black and associated noncoding sequences in 
white. The PGK-neo expression cassettes (from pKJ1) and MCl-tk 
cassettes are also indicated as boxes, and the novel 4.2 kb BamHl 
(B) fragment generated following successful targeting is also marked: 
note that the probe used to detect this fragment was derived from 
genomic DNA not included in the targeting construct. Restriction sites 
are indicated with a parenthesis when the site has been ablated during 
the construction of the targeting vector. X, Xhol; Xb, Xbal; S, Spel. 
(B) A representative Southern blot of tail DNA from wild-type, heterozy- 
gous, and homozygous F2 progeny, showing the endogenous and 
mutant BamHl fragments. 
(C) Western blot analysis of adult sciatic nerve extracts for CNTF pro- 
tein (arrow). Each lane contains 200 ug of protein. 
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Figure 2. Targeting of the Murine CNTFRa Gene 
(A) Schematic representation of >35 kb of genomic DNA encom- 
passing the 10 exons of endogenous CNTFRa gene (Valenzuela et 
al., 1995), of the targeting vector constructed, and of a mutant locus 
following successful targeting: exons are indicated as boxes, with cod- 
ing portions in black and noncoding sequences as open boxes. The 
PGK-neo (replacing about 18 kb of genomic DNA, including exons 
2-5) and MC1 -t/t cassettes are also indicated as boxes, and the novel 
6.8 kb BamHl fragment generated following successful targeting is 
also marked; the probe used to detect this fragment was derived from 
genomic DNA not included in the targeting construct. Restriction sites 
are indicated with a parenthesis when the site has been ablated during 
the construction of the targeting vector. H, Hindlll; P, Pstl; B, BarnHI. 
(B) A representative Southern blot of tail DNA from wild-type, heterozy- 
gous, and homozygous F2 progeny, showing the endogenous and 
mutant BamHl fragments. 
(C) Northern blot analysis of 20 ng of total brain RNA from newborn 
CNTFRa+‘+, CNTFR&, and CNTFRa4- pups, using a rat CNTFRa cDNA 
probe. Indicated are CNTFRa precursor (small arrowhead), normal 
coding (arrow), and truncated transcripts (from the mutant allele; large 
arrowhead). 
germline at high frequency. The Fl progeny heterozygous 
for either the CNTF mutation or the CNTfRa mutation were 
viable and appeared overtly normal and fertile and were 
bred to generate mice homozygous for either the null mu- 
tation in the CNTF gene (designated C/UP) or the null 
mutation in the CNTFRa gene (designated CNTFRa-I-) 
(Figures 28 and 38, respectively). Consistent with previ- 
ous findings (Masu et al., 1993), mice we generated that 
were lacking CNTF were viable and exhibited no overt 
abnormalities. Conversely, in litters intended to generate 
mice homozygous for the null mutation in CNTFRa, ap- 
proximately 25% (45 of 169) of the newborn pups did not 
feed, as evidenced by a lack of milk in their stomachs, 
and died during the first postnatal day (Figure 3). Genotyp- 
ing by Southern blot analysis revealed that most of the 
pups exhibiting perinatal lethality (90 of 99 genotyped) 
were homozygous for the disrupted CNTFRa allele. In con- 
trast, all of the surviving pups were either wild-type or het- 
erozygous for this allele; not a single newborn mouse ho- 
mozygous for the disrupted CNTFRa allele survived longer 
than 24 hr (Figure 38). 
Like the CNTF-‘- pups, the overt appearance of the 
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Figure 3. Appearance and Viability of Mice Carring a CNTFRa Gene 
Disruption 
(A) Newborn F2 littermates from an Fl heterozygous cross showing 
that CNTFRa-‘- pups, unlike wild-type pups, do not contain milk in their 
stomachs, owing to lack of feeding. 
(B) Time course demonstrating postnatal longevity of CNTFRa” new- 
born pups, observed since time of birth. 
CNTFRP mutant pups was normal aside from the lack 
of milk in their stomachs (Figure 3A), and their weights at 
birth did not significantly differ from those of their wild-type 
littermates. However, a behavioral analysis performed 
within the first 6-8 hr after birth revealed that the mice 
homozygous for the disrupted CNTFRa allele did not move 
their jaws as notably as feeding littermates, qualitatively 
assessed by their ability to open their mouths in response 
to a tail pinch and to vibrissal pin pricks. In addition, these 
mice were unable to suckle. The dramatic viability differ- 
ences between mice lacking CNTFRa and CNTF are con- 
sistent with speculation that CNTFRa serves a critical role 
during development that does not involve CNTF, most 
likely by serving as a receptor for a second, developmen- 
tally important, CNTF-like ligand. 
Mice Lacking CNTFRa Lack Responsiveness to 
CNTF, Confirming That CNTFRa Is a Required 
CNTF Receptor Component 
Before further analyzing the phenotype of the CNTFRa-I- 
mice and comparing them with the CNTF-I- mutant mice, 
we confirmed that the gene disruptions resulted in null 
mutations. lmmunoblot analysis for CNTF protein in the 
adult sciatic nerve revealed that while wild-type nerve ex- 
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Figure 4. The CNTFRa Is the Only Functional CNTF Receptor Used 
by DRG Neurons and in the Brain 
(A) Survival of DRG neurons cultured in the presence of either NGF, 
LIF, or CNTF at 10 nglml. Data are the average f SEM of results 
from three indpendent experiments from CNTFRa+‘+(n = 2) CNTFRa+J- 
(n = 3) and CNTFRa” (n = 3) mice. 
(6) LIF (50 nglml), but not CNTF (50 nglml), can induce tyrosine phos- 
phorylation of their shared 6 subunits (LIFR6 and gp130) in brains 
isolated from CNTFRa-‘+ mice; brains from CNTF-‘- mice were used 
as control. 
tracts contained abundant amounts of CNTF protein, 
CNTF was undetectable in nerve extracts of C/VT? mice 
(see Figure 1 C). Similarly, Northern blot analysis of CNTFRa 
brain RNA levels revealed a novel truncated RNA species 
(large arrowhead) with reduced normal transcripts (arrow) 
in CNTFRa+‘- mice, and complete absence of the normal 
CNTFRa transcripts in CNTFRa-‘- mice (see Figure 2C). 
To determine whether CNTFRa is the major in vivo re- 
ceptor mediating CNTF responses, we tested whether 
neurons in the CNTfRa? mutant mice had lost the ability 
to respond to exogenously provided CNTF. Sensory neu- 
rons from the dorsal root ganglia (DRGs) of newborn 
CNTFRa-‘- mutant mice and wild-type controls were iso- 
lated and cultured in the presence of CNTF, LIF, or nerve 
growth factor (NGF), which normally mediate in vitro sur- 
vival of these neurons. As seen in Figure 4A, neurons 
cultured from the CNTFRa+ mice were comparable to 
their wild-type and CNTFRa+‘- littermates in their respon- 
siveness to both NGF and LIF, but differed in their respon- 
siveness to CNTF. The complete lack of survival in the 
presence of CNTF demonstrates that for these peripheral 
sensory neurons, CNTFRa is a required CNTF receptor 
component, and that there is not an alternate CNTF re- 
ceptor. 
We then confirmed that CNTFRa is the major CNTF 
receptor not just for peripheral neurons but for those in 
the central nervous system as well. Membrane fractions 
were prepared from CNTFRa-I- newborn brains, as well 
as from CNTF- brains to serve as controls, and used to 
compare the ability of LIF and CNTF to induce tyrosine 
phosphorylation of their shared 6 subunits, gp130 and 
LIFRB. In the absence of added factor, there was a low 
basal level of 6 subunit phosphorylation in both the 
CNTFFk- and CNTF-‘- brains (Figure 48, lanes 1 and 4). 
Following the addition of LIF, the b subunit phosphoryla- 
tion levels in both the CNTFRa+ and CNTF-I- samples 
increased as expected (lanes 3 and 6). However, the addi- 
tion of CNTF induced a phosphorylation increase in the 
CNTF-/- sample (lane 5) but not in the sample from 
CNTfRa-‘- mice (lane 2). These observations demonstrate 
that, as was the case for peripheral sensory neurons, cen- 
tral nervous system neurons do not possess a major alter- 
native CNTF receptor component that can be used by 
CNTF to activate its j3 subunits. 
Motor Neuron Number Is Dramatically Reduced in 
Brainstem Motor Nuclei and in the Spinal Cord 
of Mice Lacking CNTFRa but Not in Mice 
Lacking CNTF 
Because of the dramatic phenotypic differences between 
the mice lacking CNTFRa and those lacking CNTF, we 
decided to examine specific neuronal populations in which 
deficits could account for the phenotypic differences. Mo- 
tor neuron populations were obvious candidates, since 
embryonic motor neurons are known to respond to CNTF 
but are reportedly not affected in young mice lacking 
CNTF, raising the possibility that the putative second li- 
gand for CNTFRa could play a critical role in the normal 
development of these neurons. Because the motor neu- 
rons most likely to be involved in the feeding and suckling 
process would be found in brain stem motor neuron nuclei, 
we first counted neurons in the facial motor nucleus(FMN), 
trigeminal motor nucleus (TMN), and hypoglossal motor 
nucleus (HMN), which provide motor innervation to the 
face, jaw, and tongue musculature, respectively (Kandel 
et al., 1991). Cell counts of these motor nuclei in newborn 
pups revealed that each exhibited significant losses in 
CNTfRa-I- mice as compared with littermate controls, 
amounting to reductions of 41% in the FMN, 27% in the 
TMN, and 51% in the HMN (Table 1; e.g., Figure 5A); 
reductions were not seen in mice heterozygous for the 
CNTFRa mutation. As previously noted for the FMN in 
young mice lacking CNTF (Masu et al., 1993), we did not 
notice significant reductions in either the FMN or TMN in 
newborn mice lacking CNTF (Table 1). 
To determine whether the dramatic reduction in motor 
neuron number seen in mice lacking CNTFRa was re- 
stricted to brainstem motor nuclei or instead generally true 
of motor neuron populations, we quantitated motor neuron 
numbers in the lumbar region of the spinal cord. This motor 
neuron population exhibited about a 33% reduction in cell 
number in CNTFRaP mice as compared with wild-type 
littermate controls (Table 1; Figure 58). Furthermore, mor- 
phometric measurements showed that the cross-sectional 
area of spinal cord motor neurons of CNTFRa-‘- mice was 
significantly reduced by 12% (P < 0.0001, according to 
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Table 1. Quantitative Analysis of Motor Neuron Populations in CNTFRa-‘- and CNTf-‘- Mice Compared with Controls 
Percent Percent 
Population CNTFRa+‘+ CNTFRa-‘- of (+I+) CN Tf+‘+ CNTF-‘- of (+/+) 
Facial nucleus 2515 ‘-+ 195(n = 5) 1475+64 (n=6) 59 2490 f 117(n = 3) 2468*138(n=4) 99 
Trigeminal nucleus 935 f 42 (n = 4) 685?14 (n=5) 73 819?80 (n=3) 852 f 46 (n = 4) 104 
Hypoglossal nucleus 1005&68 (n=3) 437 * 52 (n = 3) 44 
Spinal cord, lumbar 1983?46 (n=3) 1333 % 135(n = 3) 67 
Numbers provided are the average & SEM; n refers to the number of animals examined. Approximately 16 sections were examined for each 
specimen of the facial nucleus, 12 sections for the trigeminal nucleus, 16 sections for the hypoglossal nucleus, and 200 sections for the lumbar 
spinal cord; the counts were not corrected for split nucleoli. 
the two-tailed t test controlled for Leven’s test for equality 
of variance) compared with the areaof those from wild-type 
controls (the reduction was from a mean area of 364.7 + 
8.4 pm’ in 100 cells counted from three wild-type animals 
to an area of 321.2 +: 8.1 pm” in 97 cells counted from four 
CNTFRa-‘- mice). In contrast with mice lacking CNTFRa, it 
A CNTFRa +/+ CNTFRa -/- 
B CNTFRcl +/+ CNTFRcx -/- 
Figure 5. Comparison of the Facial Motor Nucleus and Lumbar Spinal 
Motor Neurons in CNTFRa Mutant and Control Mice 
Histological comparison of the facial motor nucleus (A) and lumbar 
cord spinal motor neurons (B) in CNTFRa mutant and control mice, 
depicting reduction in size of both motor neuron populations (bordered 
by arrows in top two panels), as quantitated in Table 1. DRGs adjacent 
to the spinal cord are also depicted: volume of DRGs did not vary 
significantly between CNTFRa mutant and control mice, as noted in 
Table 2. In (B), upper scale bar is 150 am, and lower bar is 40 pm. 
has been previously noted that mice lacking CNTF do not 
exhibit an effect on spinal cord motor neurons until 8 
weeks of age (Masu et al., 1993). 
The Effect of the CNTFRa Mutation on Sympathetic 
and Sensory Ganglia 
The CNTFRa is expressed on sensory neurons in embry 
onic DRGs and trigeminal sensory ganglia (TGs), as well 
as on sympathetic neurons in the superior cervical ganglia 
(SCGs); CNTF is known to elicit survival and differentiative 
responses from DRG and SCG neurons. To begin to deter- 
mine whether the putative second ligand for the CNTFRa 
might be as critical for the normal development of these 
neurons, as it appears to be for the normal development 
of motor neuron populations, we performed a preliminary 
histological analysis of these ganglia. Volumetric mea- 
surements revealed that the size of L5 DRGs, TGs, and 
SCGs were unaffected by the CNTFRa gene disruption 
(Table 2). Histological examination of these ganglia did 
not reveal substantial morphological differences in their 
neuronal populations in CNTFRa+ and control mice (e.g., 
Figure 58, upper panels). More extensive analysis will be 
required to determine whether these ganglia are affected 
in a more subtle manner in CNTFRc- mice, prior to ruling 
out a role of the second ligand for CNTFRa on these neu- 
ronal populations. 
Discussion 
Evidence for a Second Ligand Using 
the CNTF Receptor 
The widespread expression of CNTFRa in the developing 
nervous system, together with the well-known survival and 
differentiative effects of CNTF on many different types of 
embryonic neurons, seemed to be at odds with findings 
that CNTF itself was not prominently expressed in the em- 
Table 2. Volumetric Analysis of Peripheral Ganglia in CNTFRa-‘- 
Mice Compared with Controls 
Percent 
Population CNTFRa+‘+ CNTFRc- of (+I+) 
L5 DRG 26.8 f 2.9 (n = 4) 26.3 f 6.2 (n = 5) 98 
TG 106.3 f 15.3 (n = 3) 101.3 f 14.7 (n = 3) 95 
SCG 45.3 f 7.6 (n = 3) 47.3 r 10.8 (n = 3) 104 
Numbers are the average volumes x IO6 pm3 f SEM. DRG, dorsal 
root ganglia; TG, trigeminal ganglia: SCG, superior cervical ganglia. 
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bryo, and that mice and humans lacking CNTF did not 
exhibit any notable problems with the development of their 
nervous systems. This apparent paradox led to specula- 
tion first that CNTFRa might bind a second CNTF-like li- 
gand; second, that this alternative ligand might be much 
more critical during normal development than CNTF itself; 
and third, that the actions of exogenously provided CNTF 
on embryonic neurons might simply reflect the more physi- 
ologically relevant actions of this CNTF-like factor (Ip et 
al., 1993). We now provide compelling genetic evidence 
supporting the notion that CNTFRa is indeed utilized by 
a ligand other than CNTF, that this factor is critical for 
normal development and postnatal viability, and that it is 
particularly required for the normal development of all mo- 
tor neuron populations examined. This genetic evidence 
comes from the comparative analysis of mutant mice car- 
rying either CNTFor CNTFRa gene disruptions. While mice 
lacking CNTF are viable, initially thrive, and only late in 
life develop a mild loss of motor neurons as previously 
described (Masu et al., 1993), mice lacking CNTFRa are 
much more severely affected; they cannot feed, suffer 
from profound reductions in their motor neuron numbers, 
and die on the day of birth. 
Until the putative second ligand for CNTFRa is identi- 
fied, it cannot be excluded that the discrepancy in pheno- 
types between the CNTFRa-‘- and CNTF-‘- mice results 
from a ligand-independent role of CNTFRa that is critical 
for proper neuronal development. However, discrepancy 
between the phenotype resulting from the lack of a ligand 
as compared with the phenotype stemming from the lack 
of its cognate receptor has been seen in other systems. 
In all these cases, the discrepancy has been explained 
by the fact that the receptor does indeed prove to be uti- 
lized by multiple closely related ligands. For example, hu- 
mans lacking interleukin-2 are mildly affected as com- 
pared with individuals mutant in the interleukin-2 y 
receptor component, who suffer from severe combined 
immunodeficiency, as this receptor component is also uti- 
lized by interleukin-4, interleukin-7, interleukin-13, and in- 
terleukin-15/T (Noguchi et al., 1993; Nowak, 1993). Like- 
wise, mice lacking the insulin-like growth factor I receptor 
(Liu et al., 1993) are more severely compromised than 
micelackinginsulin-likegrowthfactor I(Bakeretal., 1993), 
because this receptor is also utilized by the developmen- 
tally important insulin-like growth factor II (DeChiara et 
al., 1990). Similarly, some neuronal populations are much 
more dramatically affected in mice lacking TrkB than in 
mice lacking brain-derived neurotrophic factor (BDNF) 
(Klein et al., 1993; Ernfors et al., 1994; Jones et al., 1994) 
presumably because TrkB serves as the in vivo receptor 
for other neurotrophins as well (Ip et al., 1993; Snider, 
1994). Supporting this notion, particular neuronal popula- 
tions (i.e., nodose sensory neurons) are similarly reduced 
in mice lacking both BDNF and neurotrophin4, as they 
are in mice lacking TrkB (Conover et al., 1995). Thus, 
CNTFRa resembles not only other growth factor recep- 
tors, but more specifically other neurotrophic factor recep- 
tors, in that it appears to be utilized by multiple ligands 
in vivo. Interestingly, CNTFRa is somewhat unusual as 
compared with these and other promiscuous receptor 
components, in that it functions solely as a specificity- 
determining subunit, and not as a signal transducer, mak- 
ing it the first example of a specificity-determining subunit 
that is shared by multiple ligands. It remains to be deter- 
mined whether the presumptive alternative ligand for 
CNTFRa utilizes the same signal-transducing 6 compo- 
nents as does CNTF. 
Are any of the known members of the CNTF cytokine 
family likely candidates for the alternative ligand utilizing 
CNTFRa? Examination of available data argues that each 
of these ligands is an improbable choice. LIF, OSM, IL-6, 
and IL-11 neither require nor seem to bind CNTFRa in 
vitro (Stahl and Yancopoulos, 1994); the recently identified 
cardiotrophin 1 acts on cells that do not express CNTFRa 
and thus also does not appear to require this receptor 
component (Pennicaet al., 1995). Furthermore, disruption 
of the genes for LIF or IL-6 does not yield phenotypes 
resembling that seen in mice lacking CNTFRa (Stewart 
et al., 1992; Escary et al., 1993; Kopf et al., 1994). Growth- 
promotingactivity(GPA) isaCNTFrelative recently cloned 
from chicken (Leung et al., 1992). Because we have not 
been able to clone another CNTF homolog from chick fol- 
lowing extensive PCR-based and low stringency homol- 
ogy cloning efforts (N. Y. I., P. Masiakowski, and G. D. Y., 
unpublished data), GPA appears to be the closest chicken 
counterpart to CNTF rather than a new family member. 
Thus, it seems that our genetic evidence points toward 
the existence of a heretofore undescribed CNTF relative 
that shares the CNTF specificity-determining component, 
CNTFRa; this ligand may share only limited homology with 
CNTF, on the basis of our inability to clone it via homology- 
based approaches. In addition to this novel and neurally 
acting CNTF-like relative, it is possible that other members 
of the CNTF/LIF/IL-6/lL-1 i/OSM/cardiotrophin 1 family, 
which do not bind CNTFRa, remain to be discovered. Re- 
cent analyses of mice lacking LlFRf3 reveal that they die 
at birth, as we have described for mice lacking CNTFRa, 
but also that they exhibit much more widespread prob- 
lems, in the development of bone, glycogen metabolism, 
placenta, and glia, than we have observed in mice lacking 
CNTFRa (Ware et al., 1995; T. D., C. S., C. Ware, and 
G. D. Y., unpublished data). Because these widespread 
abnormalities have also not been found in mice lacking 
LIF, it seems likely that LIFRP is shared in vivo not only 
by the LIF and CNTF receptor systems, but by yet another 
widely acting cytokine; OSM and cardiotrophin 1 may cor- 
respond to this cytokine. 
Role of the Alternative CNTFRa Ligand 
during Motor Neuron Development 
On the basis of our analysis, it remains unclear as to pre- 
cisely why motor neuron numbers are reduced in the mice 
lacking CNTFRa. If the presumptive new ligand for 
CNTFRa acts as a classic target-derived neurotrophic fac- 
tor during embryonic development, it may well be regulat- 
ing survival of nascent motor neurons during the period 
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of naturally occurring cell death that takes place just after 
these neurons contact their target, the developing muscle; 
for facial and lumbar cord motor neurons, this process is 
complete by late gestation in the mouse (Lance-Jones, 
1982; Ashwell and Watson, 1983). Alternatively, the new 
CNTFRa ligand may be involved in the generation of motor 
neurons, by modulating the proliferation or differentiation 
of precursors, and thus the lack of CNTFRa expression 
may result in reduced production of motor neurons; recent 
findings that CNTF can collaborate with other factors to 
promote the differentiation of neuronal precursors is con- 
sistent with this possibility (Ip et al., 1994). Clearly, a de- 
tailed analysis of motor neuron development in embryos 
lacking CNTFRa is required to understand precisely the 
actions of the new CNTFRa ligand on these neurons. 
Many neurotrophic agents have been shown to act on 
motor neurons in vitro or when artificially supplied in vivo. 
The physiological relevance of most of these agents for 
motor neuron development remains unclear. It had been 
reported that newborn mice lacking TrkB tyrosine kinase 
receptors displayed motor neuron deficits and consistently 
died within the first postnatal week (Klein et al., 1993). 
More recently, and upon continuous breeding into a 
C57BU6 background, the TrkB-defective mice survive up 
to 3 weeks of age and do not display significant motor 
neuron deficits (I. Silos-Santiago and M. Barbacid, per- 
sonal communication). These observations resemble re- 
cent results obtained with mice lacking both BDNF and 
NT-4 (Conover et al., 1995; Liu et al., 1995) and suggest 
that signaling through TrkB receptors is not required for 
the generation of normal numbers of motor neurons during 
development. Analysis of mice disrupted for the CNTFRa 
gene appears to have defined a neurotrophic factor recep- 
tor system essential for normal motor neuron development 
in vivo. It should be noted, however, that substantial num- 
bers of motor neurons, albeit somewhat atrophic, remain 
in newborn mice lacking CNTFRa. Therefore, it remains 
quite possible that motor neurons depend on additional 
classes of neurotrophic factors. It will be interesting to 
determine whether such ligands function independently 
or cooperatively with ligands using the CNTF receptor sys- 
tem, since collaborative and synergistic interactions be- 
tween CNTF and other classes of factors have been dem- 
onstrated (e.g., Ip et al., 1994; Mitsumoto et al., 1994). It 
also will be necessary to determine if such factors act 
on distinct motor neuron subpopulations. Just as distinct 
motor neuron subsets can be defined on the basis of their 
target specificities and their patterns of LIM homeobox 
gene expression (Lewin, 1994; Tsuchida et al., 1994), it 
may be found that different motor neuron subsets display 
distinct neurotrophic requirements in vivo; such subsets 
have been defined for sensory neuron populations in the 
dorsal root ganglia (Snider, 1994) or nodose ganglia (Con- 
over et al., 1995). 
Experimental Procedures 
Targeting Vectors and ES Cells 
Targeting vectors were constructed from mouse genomic DNA frag- 
ments isolated from an EMBL3 h phage library prepared with BALBlc 
strain DNA (Clontech). For the CNTF replacement vector, a 5.4 kb 
genomic Xhol-Xbal DNA fragment containing the two coding axons 
of the CNTF gene and flanking sequences was subcloned into the 
corresponding sites of the polylinker of the pKS Bluescript (Promega) 
plasmid (Figure IA); an Xhol-Sall 1.85 kb DNA fragment containing 
the MCI-thymidine kinase (f/q expression cassette was cloned into 
the unique Xhol site in this plasmid, and the resulting plasmid was 
digested with Spel to releasea 1.5 kb DNAfragment(containingcoding 
exons 1 and 2 of the CNTF gene) that was then replaced with the 
phosphoglycerate kinase (PGK)-neo expression cassette flanked with 
Xbal linkers to allow cloning into the compatible Spel site (Figure 1A). 
For the CNTFRa replacement vector, an 6 kb Hindlll-BamHI DNA 
fragment including exon 1 from the 5’ end of the CNTFRa gene was 
cloned into pKS plasmid (Figure 2A). A 1.8 kb Xhol-Hindlll DNA frag- 
ment containing the MCI-tk expression cassette was cloned into the 
unique Xhol-Hindlll sites of this plasmid, while a 1.8 kb Bglll DNA 
fragment containing the PGK-neo expression cassette was cloned 
into the unique BamHl site. A 3 kb Hindlll-Pstl DNA fragment from 
the 3’ end of the CNTFRa gene, containing exons 8, 9, and 10, was 
blunt-ended, flanked with Xbal linkers, and cloned into the uniquexbal 
site to complete the targeting vector (Figure 2A). Both targeting vectors 
were linearized by digestion with Not1 and then electroporated into 
E14.1 ES cells, which were grown in 200 ug/ml G418 (GIBCO) and 2 
uM gancyclovir; gancyclovir addition resulted in a 5- to lo-fold enrich- 
ment compared with selection in G418 alone. 
Culture of Dissociated Neurons Isolated from DRGs 
DRGs were dissected from Pl mice, desheathed, trypsinized, and 
mechanically dissociated, then preplated on a polyornithine substrate 
for 2 hr to allow nonneuronal cells to attach. Neurons, which remained 
unattached, were harvested and then plated onto 48-well dishes 
coated with polyornithine-laminin (approximately 2000 cells per well) 
and counted. Either NGF, LIF, or CNTF was added, and 24 hr later, 
the number of surviving neurons was assessed in each well by count- 
ing. Data are expressed as percent neuronal survival, i.e., the number 
of surviving neurons at the end of 24 hr relative to the number of 
neurons initially plated. 
Phophorylation Assays, Immunoblotting, 
and Northern Blotting 
To determine CNTF or LIF responsivity in newborn brains, the dis- 
sected Pl mouse brains were triturated on ice in 0.75 ml of PBS into a 
fine suspension. Each sample was then equally divided and incubated 
with either control solution, CNTF (50 nglml), or LIF (50 nglml) for 
15 min at room temperature with gentle agitation. Receptor complex 
activation was determined by LIFRP immunoprecipitation and phos- 
photyrosine immunoblotting as described (Stahl et al., 1993, 1994). 
For CNTF detection in sciatic nerves from adult CNTF-‘- or CNlF+‘+ 
mice, the nerves were homogenized in buffer containing 20 mM Tris 
(pH 7.6) 1 mM EDTA, 150 mM NaCI, 1 mM sodium orthovanadate, 
10 pg/ml leupeptin, 10 Kg/ml aprotinin, and 1 mM PMSF and spun at 
13,000 x g for 20 min. The supernatants were then concentrated with 
a Centricon- concentrator (Amicon) and quantified by using the BCA 
reagents (Pierce), and -200 ug of protein was loaded in each lane 
of a 12% polyacrylamide gel, which was then immunoblotted with 
the CNTF-specific polyclonal antibody RG0036. Northern blotting for 
CNTFRa RNA was performed as previously described (Ip et al., 1993). 
Motor Neuron Cell Counting and Morphometric Analysis 
Newborns were anesthetized and perfused with 3 ml of 0.9% NaCl 
containing 5 U/ml of heparin followed by3 ml of 4% paraformaldehyde 
in PBS (pH 7.4-7.6) and postfixed in 4% paraformaldehyde at 4OC. 
The brain and spinal cords were dissected out and cryoprotected by 
incubation in successive solutions of 17% and 30% sucrose in PBS 
at 4OC. Tissues were embedded in OCT compound (Miles Laboratory, 
Incorporated) and frozen at -58OC (spinal cord) or -30°C (brains) in 
isopentane cooled on dry ice. Cryostat serial sections of 20 urn (spinal 
cord) or 30 urn (brain) were mounted on gelatin-coated glass cov- 
erslips, air-dried, and stained with 0.1% cresyl violet. In some cases, 
the entire vertebral column including the cord was mounted in the 
coronal plane and sectioned. Large cells in the ventral horns with 
abundant cytoplasm and a prominent nucleolus were counted on both 
Cell 
320 
sides; in the facial, trigeminal, and hypoglossal motor nuclei, large 
cells with a distinct nucleus were counted. Cross-section area of motor 
neurons was measured in sections 30 Km thick stained with cresyl 
violet, by using a PC-assisted image analysis system (Software Qwin 
of the Leica Quantimat 500). Only cell profiles containing a distinct 
nucleus with nucleolus were included. Spinal motor neurons were 
measured in the L4-L5 segments. 
Volumetric Analyses of Peripheral Ganglia 
Ganglia were removed from perfused (DRGs and TGs) or nonperfused 
(SCGs) pups, postfixed as above, dehydrated in graded alcohols, and 
then paraffin-embedded. Serial sections of 6 urn were cut and mounted 
on ProbeOn Plus slides (Fisher) and stained with cresyl violet. Each 
section was microscopically examined to identify all sections that con- 
tained neuronal somata. These sections were parcellated, from the 
beginning to the end of the ganglia, into 12 groups, and by using 
systematic random sampling methods, one section from each group 
waschosenforfurtheranalysis(PoverandCoggeshall,l99l).Analysis 
was performed on a digitized image of the section by using a computer- 
assisted planimeter to measure the area occupied by neuronal cell 
bodies (Jandel Image Analysis Systems). The volume of the ganglia, 
expressed in pm3, was calculated from the product of the average 
mean area (Km*) determined from the 12 sections, the section thick- 
ness (6 pm), and the total number of sections per ganglion. 
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